18FDG-PET for the assessment of primary head and neck tumors: Clinical, computed tomography, and histopathological correlation in 38 patients

Laryngoscope

Volumn 108, Issue 10, 1998, Pages 1578-1583

  Paulus, Partrick ^a,b   Sambon, A ^a   Vivegnis, D ^a   Hustinx, R ^a   Moreau, P ^a   Collignon, J ^a   Deneufbourg, J M ^a   Rigo, P ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHU SART TILMAN   (Belgium)

Author keywords

FDG PET; Head and neck cancer; Lymph node metastases; Recurrent disease

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOREIGN BODY GRANULOMA; HEAD AND NECK CANCER; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HEAD AND NECK TUMOR; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031595345     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199810000-00029     Document Type: Article

References (24)

1. Moreau P, Goffart Y, Collignon J. Computed tomography of metastatic cervical lymph nodes. Arch Otolaryngol Head Neck 1990;116:1190-3.
2. Stern WB, Silver CE, Zeifer BA, et al. Computed tomography of the clinically negative neck. Head Neck Surg 1990;12:109-13.
3. Hillsamer PJ, Schuller DE, McGhee RB, et al. Improving diagnostic accuracy of cervical metastases with computed tomography and magnetic resonance imaging. Arch Otolaryngol Head Neck Surg 1990;116:1297-301.
4. Madison MT, Remley KB, Latchaw RE, Mitchell SL. Radiologic diagnosis and staging of head and neck squamous cell carcinoma. Radiol Clin North Am 1994;32:163-81.
5. Million RR, Cassisi NJ. Oral cavity. In: Million RR, Cassisi NJ, eds. Management of Head and Neck Cancer: A Multidisciplinary Approach, edn 2. Philadelphia: J.B. Lippincott; 1994:239-98.
6. Mukherji SK, Mancuso AA, Korsur IM, et al. Radiologic appearance of irradiated larynx. II. Primary site response. Radiology 1994;193:149-54.
7. Gussack GS, Hudgin PA. Imaging modalities in recurrent head and neck tumors. Laryngoscope 1991;101:119-24.
8. Hudgins PA, Burson JG, Guack GS, et al. CT and MR appearance of recurrent malignant head and neck neoplasm after resection and flap reconstruction. AJNR Am J Neuroradiol 1994;15:1689-94.
9. Anzai Y, Blackwell KE, Hirschowitz SL, et al. Initial clinical experience with dextran-coated supramagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 1994;192:709-15.
10. Anzai Y, Prince MR. Iron oxide-enhanced MR lymphography: the evaluation of cervical lymph node metastases in head and neck cancer. J Magn Reson Imaging 1997;7:75-81.
11. Som PM. Lymph nodes. In: Som PM, Curtin HD, eds. Head and Neck Imaging, edn 3, vol 2. St. Louis: Mosby-Year Book, Inc.: 1996:772-93.
12. Benchaou M, Lehmann W, Slosman DO, et al. The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer. Acta Otol Laryngol 1996;116:332-5.
13. Rege S, Maass A, Chaiken L, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 1994;73:3047-58.
14. McGuirt WF, Williams DW III, Keyes JW, et al. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope 1995;105:373-5.
15. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995;36:1747-57.
16. Van den Brekel MW, Castelijns JA, Snow GB. The role of modern imaging studies in staging and therapy of head and neck neoplasms. Semin Oncol 1994;21:340-8.
17. Wong WL, Chevretton E, McGurck M, Croft D. FDG-PET imaging in the clinical evaluation of head and neck cancer. J R Soc Med 1995;88:469-73.
18. Bailet JW, Abemayor E, Jabour BA, et al. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992;102:281-8.
19. Braams JW, Pruim J, Frelin NJM, et al. Detection of lymph node metastases of squamous cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995;36:211-6.
20. Lindholm P, Leskinen-Kallio S, Grenman R, et al. Evaluation of response to radiotherapy in head and neck cancer by positron emission tomography and 11C Methionine. Int J Radiat Oncol Biol Phys 1995;32:787-94.
21. Bailet JW, JA Sercarz E, Abemayor, et al. Use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients. Laryngoscope 1995;105:135-9.
22. Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-F-18 fluoro-2-deoxy-D-glucose. Radiology 1995;197:205-11.
23. Greven KM, Williams DW, Keyes JW, et al. Positron emission tomography of patients with head and neck carcinoma before and after high-dose irradiation. Cancer 1994;74:1355-9.
24. Karp JS, Muehehllner H, Qu H, Yan XH. Singles transmission in volume-imaging PET with a 137 Cs source. Phys Med Biol 1995;40:929-44.